Management of endocrine disease: risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects

Abiraterone and Increased Survival in Metastatic Prostate Cancer

de Bono, J. S., Logothetis, C. J., Molina, A., Fizazi, K., North, S., Chu, L., Chi, K. N., Jones, R. J., Goodman, O. B., Saad, F., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014618 · Cited by 4,407 · see citing works

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

Beer, T. M., Armstrong, A. J., Rathkopf, D. E., Loriot, Y., Sternberg, C. N., Higano, C. S., Iversen, P., Bhattacharya, S., Carles, J., Chowdhury, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1405095 · Cited by 3,028 · see citing works

Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

Ryan, C. J., Smith, M. R., de Bono, J. S., Molina, A., Logothetis, C. J., de Souza, P., Fizazi, K., Mainwaring, P., Piulats, J. M., Ng, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209096 · Cited by 2,796 · see citing works

Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline

Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769 · see citing works

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline.

Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,484 · see citing works

Premature mortality due to cardiovascular disease in hypopituitarism

Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · see citing works

Diagnosis and complications of Cushing’s syndrome: a consensus statement

Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362 · see citing works

Glucocorticoid-induced osteoporosis: pathophysiology and therapy

CANALIS, E. M., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,118 · see citing works

Association between premature mortality and hypopituitarism

Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006 · see citing works

Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.

Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886 · see citing works

Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction

Betterle, C., Dal Pra, C., Mantero, F., & Zanchetta, R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0466 · Cited by 758 · see citing works

The effects of opioids and opioid analogs on animal and human endocrine systems

Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564 · see citing works

Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients

Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506 · see citing works

Premature Mortality in Patients with Addison’s Disease: A Population-Based Study

Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0076 · Cited by 490 · see citing works

Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry

ESTEBAN, N. V., LOUGHLIN, T., YERGEY, A. L., ZAWADZKI, J. K., BOOTH, J. D., WINTERER, J. C., & LORIAUX, D. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-39 · Cited by 481 · see citing works

Clinical, Immunological, and Genetic Features of Autoimmune Primary Adrenal Insufficiency: Observations from a Norwegian Registry

Erichsen, M. M., Løvås, K., Skinningsrud, B., Wolff, A. B., Undlien, D. E., Svartberg, J., Fougner, K. J., Berg, T. J., Bollerslev, J., Mella, B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1368 · Cited by 422 · see citing works

Consensus statement on the diagnosis, treatment and follow‐up of patients with primary adrenal insufficiency

Husebye, E. S., Allolio, B., Arlt, W., Badenhoop, K., Bensing, S., Betterle, C., Falorni, A., Gan, E. H., Hulting, A. ‐., Kasperlik‐Zaluska, A., et al. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12162 · Cited by 403 · see citing works

High Incidence of Adrenal Crisis in Educated Patients With Chronic Adrenal Insufficiency: A Prospective Study

Hahner, S., Spinnler, C., Fassnacht, M., Burger-Stritt, S., Lang, K., Milovanovic, D., Beuschlein, F., Willenberg, H. S., Quinkler, M., & Allolio, B. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3191 · Cited by 394 · see citing works

Mortality in Patients with Pituitary Disease

Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392 · see citing works

Glucocorticoid-induced osteoporosis: an update

Mazziotti, G., Angeli, A., Bilezikian, J. P., Canalis, E., & Giustina, A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.03.009 · Cited by 362 · see citing works

Hypopituitarism

Schneider, H. J., Aimaretti, G., Kreitschmann-Andermahr, I., Stalla, G.-K., & Ghigo, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60673-4 · Cited by 336 · see citing works

Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Berruti, A., Baudin, É., Gelderblom, H. A. J., Haak, H. R., Porpiglia, F., Faßnacht, M., & Pentheroudakis, G. (2012) · Annals of Oncology · doi:10.1093/annonc/mds231 · Cited by 330 · see citing works

Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation

Johannsson, G., Nilsson, A. G., Bergthorsdottir, R., Burman, P., Dahlqvist, P., Ekman, B., Engström, B. E., Olsson, T., Ragnarsson, O., Ryberg, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1926 · Cited by 329 · see citing works

The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients

Filipsson, H., Monson, J. P., Koltowska-Häggström, M., Mattsson, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0524 · Cited by 321 · see citing works

Clinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate Cancer

Attard, G., Reid, A. H. M., Auchus, R. J., Hughes, B. A., Mulick, A. R., Thompson, E., Oommen, N. B., Folkerd, E. J., Dowsett, M., Arlt, W., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2189 · Cited by 284 · see citing works

Impaired Subjective Health Status in 256 Patients with Adrenal Insufficiency on Standard Therapy Based on Cross-Sectional Analysis

Hahner, S., Loeffler, M., Fassnacht, M., Weismann, D., Koschker, A.-C., Quinkler, M., Decker, O., Arlt, W., & Allolio, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0685 · Cited by 282 · see citing works

Drug-induced Osteoporosis: Mechanisms and Clinical Implications

Mazziotti, G., CANALIS, E. M., & Giustina, A. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.02.028 · Cited by 259 · see citing works

Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer

Li, Z., Bishop, A. C., Alyamani, M., Garcia, J. A., Dreicer, R., Bunch, D. R., Liu, J., Upadhyay, S. K., Auchus, R. J., & Sharifi, N. (2015) · Nature · doi:10.1038/nature14406 · Cited by 258 · see citing works

Subjective health status in Norwegian patients with Addison’s disease.

Løvås, K., Loge, J. H., & Husebye, E. S. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01466.x · Cited by 256 · see citing works

Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100

Richards, J., Lim, A. C., Hay, C. W., TAYLOR, A. E. R., Wingate, A., Nowakowska, K., Pezaro, C. J., Carreira, S., GOODALL, J. C., Arlt, W., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3980 · Cited by 255 · see citing works

Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency

Mah, P. M., Jenkins, R. C., Rostami‐Hodjegan, A., Newell‐Price, J., Doane, A., Ibbotson, V., Tucker, G. T., & Ross, R. J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02106.x · Cited by 243 · see citing works

Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients

Bleicken, B., Ventz, M., Quinkler, M., & Hahner, S. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181db6b7a · Cited by 242 · see citing works

Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency

Bensing, S., Brandt, L., Tabaroj, F., Sjöberg, O., Nilsson, B., Ekbom, A., Blomqvist, P., & Kämpe, O. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03340.x · Cited by 242 · see citing works

Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death

Erichsen, M. M., Løvås, K., Fougner, K. J., Svartberg, J., Hauge, E. R., Bollerslev, J., Berg, J. P., Mella, B., & Husebye, E. S. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0550 · Cited by 240 · see citing works

Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis

Kerrigan, J. R., Veldhuis, J. D., Leyo, S. A., Iranmanesh, A., & Rogol, A. D. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501158 · Cited by 228 · see citing works

Metabolic Effects of Short-Term Elevations of Plasma Cortisol Are More Pronounced in the Evening Than in the Morning¹

Plat, L., Leproult, R., L’Hermite-Baleriaux, M., Fery, F., Mockel, J., Polonsky, K. S., & Van Cauter, E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.5978 · Cited by 225 · see citing works

High prevalence and increasing incidence of Addison's disease in western Norway

Løvås, K., & Husebye, E. S. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.t01-1-01552.x · Cited by 221 · see citing works

Effect of Glucocorticoid Replacement Therapy on Bone Mineral Density in Patients with Addison Disease

Zelissen, P. M. J., CROUGHS, R. J. M., van Rijk, P. P., & Raymakers, J. A. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00005 · Cited by 220 · see citing works

Eight-six Cases of Adison's Disease

Dunlop, D. (1963) · BMJ · doi:10.1136/bmj.2.5362.887 · Cited by 216 · see citing works

Is the Prevalence of Addison's Disease Underestimated?

Laureti, S., Vecchi, L., Santeusanio, F., & Falorni, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5677-7 · Cited by 211 · see citing works

Clinical applications of cortisol measurements in hair

Wester, V. L., & van Rossum, E. F. C. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0313 · Cited by 210 · see citing works

Glucocorticoids and the regulation of growth hormone secretion

Mazziotti, G., & Giustina, A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.5 · Cited by 206 · see citing works

Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study

Falhammar, H., Frisén, L., Hirschberg, A. L., Norrby, C., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2093 · Cited by 204 · see citing works

Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Falhammar, H., Frisén, L., Norrby, C., Hirschberg, A. L., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2957 · Cited by 196 · see citing works

11β-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects

Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1050 · Cited by 196 · see citing works

Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells

Sbiera, S., Leich, E., Liebisch, G., Sbiera, I., Schirbel, A., Wiemer, L., Matysik, S., Eckhardt, C., Gardill, F., Gehl, A., et al. (2015) · Endocrinology · doi:10.1210/en.2015-1367 · Cited by 194 · see citing works

Diabetes in Cushing syndrome: basic and clinical aspects

Mazziotti, G., Gazzaruso, C., & Giustina, A. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.09.001 · Cited by 193 · see citing works

Pathophysiology of Dyslipidemia in Cushing’s Syndrome

Arnaldi, G., Scandali, V. M., Trementino, L., Cardinaletti, M., Appolloni, G., & Boscaro, M. (2010) · Neuroendocrinology · doi:10.1159/000314213 · Cited by 189 · see citing works

The Diagnosis and Management of Central Hypoadrenalism

Grossman, A. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0982 · Cited by 187 · see citing works

Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality

Burman, P., Mattsson, A. F., Johannsson, G., Höybye, C., Holmer, H., Dahlqvist, P., Berinder, K., Engström, B. E., Ekman, B., Erfurth, E. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4059 · Cited by 184 · see citing works

Metabolic Effects of Short-Term Elevations of Plasma Cortisol Are More Pronounced in the Evening Than in the Morning

Plat, L. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.9.3082 · Cited by 177 · see citing works

Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study

Johannsson, G., Bergthorsdottir, R., Nilsson, A. G., Lennernas, H., Hedner, T., & Skrtic, S. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0170 · Cited by 173 · see citing works

Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly

Daffara, F., De Francia, S., Reimondo, G., Zaggia, B., Aroasio, E., Porpiglia, F., Volante, M., Termine, A., Di Carlo, F., Dogliotti, L., et al. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0103 · Cited by 167 · see citing works

Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone.

Løvås, K., Gjesdal, C., Christensen, M., Wolff, A. B., Almås, B., Svartberg, J., Fougner, K., Syversen, U., Bollerslev, J., Falch, J., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0880 · Cited by 166 · see citing works

Mitotane for adrenocortical carcinoma treatment.

Hahner, S., & Faßnacht, M. (2005) · PubMed · Cited by 153 · see citing works

Cardiovascular Risk in Adult Patients With Growth Hormone (GH) Deficiency and Following Substitution With GH—An Update

Gazzaruso, C., Gola, M., Karamouzis, I., Giubbini, R., & Giustina, A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2394 · Cited by 151 · see citing works

Fractures and bone mineral density in adult women with 21-hydroxylase deficiency

Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0744 · Cited by 151 · see citing works

Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself

Dinsen, S., Baslund, B., Klose, M., Rasmussen, A. K., Friis-Hansen, L., Hilsted, L., & Feldt-Rasmussen, U. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.05.014 · Cited by 148 · see citing works

Influence of hydrocortisone dosage scheme on health‐related quality of life in patients with adrenal insufficiency

Bleicken, B., Hahner, S., Loeffler, M., Ventz, M., Decker, O., Allolio, B., & Quinkler, M. O. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03596.x · Cited by 148 · see citing works

Bone Mineral Density Is Not Significantly Reduced in Adult Patients on Low-Dose Glucocorticoid Replacement Therapy

Koetz, K., Ventz, M., Diederich, S., & Quinkler, M. O. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2036 · Cited by 141 · see citing works

Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements

Arlt, W., Rosenthal, C., Hahner, S., & Allolio, B. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02473.x · Cited by 138 · see citing works

Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy

Debono, M., Ross, R. J. M., & Newell-Price, J. D. C. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0874 · Cited by 137 · see citing works

Growth Hormone and Cardiovascular Risk Factors

Gola, M., Bonadonna, S., Doga, M., & Giustina, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0545 · Cited by 135 · see citing works

Overall and cause-specific mortality in GH-deficient adults on GH replacement

Gaillard, R. C., Mattsson, A. F., Åkerblad, A., Bengtsson, B., Cara, J. F., Feldt‐Rasmussen, U., Kołtowska‐Häggström, M., Monson, J. P., Saller, B., Wilton, P., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1028 · Cited by 130 · see citing works

Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome

Falhammar, H., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0656-0 · Cited by 127 · see citing works

Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency

Quinkler, M. O., Nilsen, R. M., Zopf, K., Ventz, M., & Øksnes, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1114 · Cited by 126 · see citing works

Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy

Johannsson, G., Falorni, A., Skrtic, S., Lennernäs, H., Quinkler, M., Monson, J. P., & Stewart, P. M. (2015) · Clinical Endocrinology · doi:10.1111/cen.12603 · Cited by 122 · see citing works

An oral multiparticulate, modified‐release, hydrocortisone replacement therapy that provides physiological cortisol exposure

Whitaker, M. J., Debono, M., Huatan, H., Merke, D. P., Arlt, W., & Ross, R. J. (2014) · Clinical Endocrinology · doi:10.1111/cen.12316 · Cited by 121 · see citing works

Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients

Mills, J. L., Schonberger, L. B., Wysowski, D. K., Brown, P., Durako, S. J., Cox, C., Kong, F., & Fradkin, J. E. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.12.036 · Cited by 118 · see citing works

Clinical Outcome, Hormonal Status, Gonadotrope Axis, and Testicular Function in 219 Adult Men Born With Classic 21-Hydroxylase Deficiency. A French National Survey

Bouvattier, C., Esterle, L., Renoult-Pierre, P., de la Perrière, A. B., Illouz, F., Kerlan, V., Pascal-Vigneron, V., Drui, D., Christin-Maitre, S., Galland, F., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4124 · Cited by 116 · see citing works

The Production Rate of Cortisol in Man

Cope, C. L., & Black, E. F. E. (1958) · BMJ · doi:10.1136/bmj.1.5078.1020 · Cited by 115 · see citing works

Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines

Mazziotti, G., Formenti, A. M., Adler, R. A., Bilezikian, J. P., Grossman, A. B., Sbardella, E., Minisola, S., & Giustina, A. (2016) · Endocrine · doi:10.1007/s12020-016-1146-8 · Cited by 112 · see citing works

Use of Prednisone With Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer

Auchus, R. J., Yu, M. K., Nguyen, S., & Mundle, S. D. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0167 · Cited by 111 · see citing works

Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens

Bleicken, B., Hahner, S., Loeffler, M., Ventz, M., Allolio, B., & Quinkler, M. O. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0578 · Cited by 102 · see citing works

Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison’s disease

Giordano, R., Guaraldi, F., Marinazzo, E., Fumarola, F., Rampino, A., Berardelli, R., Karamouzis, I., Lucchiari, M., Manetta, T., Mengozzi, G., et al. (2015) · Endocrine · doi:10.1007/s12020-015-0681-z · Cited by 100 · see citing works

Diamonds are forever: the cortisone legacy

Hillier, S. G. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0309 · Cited by 100 · see citing works

Quality of Life in European Patients with Addison's Disease: Validity of the Disease-Specific Questionnaire AddiQoL

Øksnes, M., Bensing, S., Hulting, A.-L., Kämpe, O., Hackemann, A., Meyer, G., Badenhoop, K., Betterle, C., Parolo, A., Giordano, R., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1901 · Cited by 99 · see citing works

Central hypoadrenalism

Crowley, R. K., Argese, N., Tomlinson, J. W., & Stewart, P. M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2476 · Cited by 97 · see citing works

Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults

Giustina, A., Barkan, A. L., Chanson, P., Grossman, A. B., Hoffman, A. R., Ghigo, E., Casanueva, F. F., Colao, A., Lamberts, S. W. J., Sheppard, M., et al. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03349263 · Cited by 96 · see citing works

A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia

Nella, A. A., Mallappa, A., Perritt, A. F., Gounden, V., Kumar, P., Sinaii, N., Daley, L.-A., Ling, A., Liu, C.-Y., Soldin, S. J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1916 · Cited by 91 · see citing works

Exploring inpatient hospitalizations and morbidity in patients with adrenal insufficiency

Stewart, P. M., Biller, B. M. K., Marelli, C., Gunnarsson, C., Ryan, M. P., & Johannsson, G. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2221 · Cited by 90 · see citing works

What Affects the Quality of Life in Autoimmune Addison's Disease?

Meyer, G., Hackemann, A., Penna-Martinez, M., & Badenhoop, K. (2013) · Hormone and Metabolic Research · doi:10.1055/s-0032-1331766 · Cited by 88 · see citing works

Growth Hormone Deficiency in Patients With Idiopathic Adrenocorticotropin Deficiency Resolves During Glucocorticoid Replacement

Giustina, A., Romanelli, G., CANDRINA, R., & Giustina, G. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-1-120 · Cited by 85 · see citing works

Long‐term follow‐up of bone mineral density in Addison's disease

Jódar, E., Valdepeñas, M. P. R., Martínez, G., Jara, A., & Hawkins, F. G. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01761.x · Cited by 84 · see citing works

Metabolic and cardiovascular profile in patients with Addison’s disease under conventional glucocorticoid replacement

Giordano, R., Marzotti, S., Balbo, M., Romagnoli, S., Marinazzo, E., Berardelli, R., Migliaretti, G., Benso, A., Falorni, A., Ghigo, E., et al. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345773 · Cited by 84 · see citing works

Risk of hip fracture in Addison’s disease: a population-based cohort study

Björnsdottir, S., Sääf, M., Bensing, S., Kämpe, O., Michaëlsson, K., & Ludvigsson, J. F. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02352.x · Cited by 82 · see citing works

Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia

Falhammar, H., Filipsson Nyström, H., Wedell, A., Brismar, K., & Thorén, M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0865 · Cited by 82 · see citing works

Biochemical and genetic diagnosis of 21-hydroxylase deficiency

Falhammar, H., Wedell, A., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0731-6 · Cited by 80 · see citing works

The risk of affective disorders in patients with adrenocortical insufficiency

Thomsen, A. F., Kvist, T. K., Andersen, P. K., & Kessing, L. V. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.01.003 · Cited by 79 · see citing works

Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE)

Han, T. S., Krone, N., Willis, D. S., Conway, G. S., Hahner, S., Rees, D. A., Stimson, R. H., Walker, B. R., Arlt, W., Ross, R. J., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0128 · Cited by 79 · see citing works

Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency

Mazziotti, G., Doga, M., Frara, S., Maffezzoni, F., Porcelli, T., Cerri, L., Maroldi, R., & Giustina, A. (2016) · Endocrine · doi:10.1007/s12020-015-0738-z · Cited by 78 · see citing works

Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency: Quality of life in adult CAH patients

Reisch, N., Hahner, S., Bleicken, B., Flade, L., Pedrosa Gil, F., Loeffler, M., Ventz, M., Hinz, A., Beuschlein, F., Allolio, B., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03920.x · Cited by 78 · see citing works

Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency

Schulz, J., Frey, K. R., Cooper, M. S., Zopf, K., Ventz, M., Diederich, S., & Quinkler, M. O. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1096 · Cited by 77 · see citing works

Modified release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia

Jones, C. M., Mallappa, A., Reisch, N., Nikolaou, N., Krone, N., Hughes, B. A., O’Neil, D. M., Whitaker, M. J., Tomlinson, J. W., Storbeck, K.-H., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2855 · Cited by 74 · see citing works

Psychological morbidity and impaired quality of life in patients with stable treatment for primary adrenal insufficiency: cross-sectional study and review of the literature

Tiemensma, J., Andela, C. D., Kaptein, A. A., Romijn, J. A., van der Mast, R. C., Biermasz, N. R., & Pereira, A. M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0023 · Cited by 73 · see citing works

The endocrinology of adrenal tuberculosis: The effects of tuberculosis on the hypothalamo-pituitary-adrenal axis and adrenocortical function

Keleştimur, F. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03351067 · Cited by 72 · see citing works

Management of Congenital Adrenal Hyperplasia: Results of the ESPE Questionnaire

Riepe, F. G., Krone, N., Viemann, M., Partsch, C.-J., & Sippell, W. G. (2002) · Hormone Research in Paediatrics · doi:10.1159/000065492 · Cited by 72 · see citing works

Increased Abdominal Adiposity in Adolescents and Young Adults With Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

Kim, M. S., Ryabets‐Lienhard, A., Dao-Tran, A., Mittelman, S. D., Gilsanz, V., Schrager, S. M., & Geffner, M. E. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4033 · Cited by 71 · see citing works

MANAGEMENT OF ENDOCRINE DISEASE: Epidemiology, quality of life and complications of primary adrenal insufficiency: a review

Bensing, S., Hulting, A., Husebye, E. S., Kämpe, O., & Løvås, K. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1242 · Cited by 68 · see citing works

Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency

Mazziotti, G., Porcelli, T., Bianchi, A., Cimino, V, Patelli, I., Mejia, C., Fusco, A., Giampietro, A., De Marinis, L., & Giustina, A. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0125 · Cited by 68 · see citing works

Drug-related hypertension and resistance to antihypertensive treatment

Rossi, G. P., Seccia, T. M., Maniero, C., & Pessina, A. C. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834c465d · Cited by 68 · see citing works

Novel strategies for hydrocortisone replacement

Debono, M., Price, J., & Ross, R. J. M. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.010 · Cited by 65 · see citing works

Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR

Murray, R. D., Ekman, B., Uddin, S., Marelli, C., Quinkler, M. O., ZELISSEN, P. M. J., & the EU-AIR Investigators (2016) · Clinical Endocrinology · doi:10.1111/cen.13267 · Cited by 62 · see citing works

Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency

Quinkler, M. O., Ekman, B., Marelli, C., Uddin, S., ZELISSEN, P. M. J., Murray, R. D., & _, _. (2016) · Endocrine Connections · doi:10.1530/ec-16-0081 · Cited by 61 · see citing works

Cytochrome P450-Catalyzed Binding of 3-Methylsulfonyl-DDE and o,p′-DDD in Human AdrenalZona Fasciculata/Reticularis

Lindhe, Ö., Skogseid, B. M., & Brandt, I. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8281 · Cited by 60 · see citing works

Therapy of adrenal insufficiency: an update

Falorni, A., Minarelli, V., & Morelli, S. (2012) · Endocrine · doi:10.1007/s12020-012-9835-4 · Cited by 56 · see citing works

Sleep disturbances in patients with Addison's disease

Løvås, K., Husebye, E., Holsten, F., & Bjorvatn, B. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480449 · Cited by 55 · see citing works

PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy

Orena, S., Maurer, T. S., She, L., Eudy, R. J., Bernardo, V., Dash, D., Loria, P. M., Banker, M. E., Tugnait, M., Okerberg, C. V., et al. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00115 · Cited by 54 · see citing works

A randomized, double‐blind, crossover study comparing two‐ and four‐dose hydrocortisone regimen with regard to quality of life, cortisol and <scp>ACTH</scp> profiles in patients with primary adrenal insufficiency

Ekman, B., Bachrach‐Lindström, M., Lindström, T., Wahlberg, J., Blomgren, J., & Arnqvist, H. J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04352.x · Cited by 54 · see citing works

Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy

Giustina, A., Bossoni, S., Bodini, C., Girelli, A., Balestrieri, G. P., Pizzocolo, G., & Wehrenberg, W. B. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.6.1592874 · Cited by 54 · see citing works

The influence of hydrocortisone substitution on the quality of life and parameters of bone metabolism in patients with secondary hypocortisolism

Wichers, M., Springer, W., BIDLINGMAIER, F., & Klingmüller, D. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00723.x · Cited by 53 · see citing works

Adrenal insufficiency in patients on long-term opioid analgesia

Gibb, F. W., Stewart, A., Walker, B. R., & Strachan, M. W. J. (2016) · Clinical Endocrinology · doi:10.1111/cen.13125 · Cited by 52 · see citing works

Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to Patients with adrenal insufficiency

Thomson, A. H., Devers, M. C., Wallace, E. M., Grant, D., Campbell, K., Freel, M., & Connell, J. M. C. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02812.x · Cited by 50 · see citing works

High prevalence of radiological vertebral fractures in adult patients with Ehlers–Danlos syndrome

Mazziotti, G., Dordoni, C., Doga, M., Galderisi, F., Venturini, M., Calzavara‐Pinton, P., Maroldi, R., Giustina, A., & Colombi, M. (2015) · Bone · doi:10.1016/j.bone.2015.12.007 · Cited by 50 · see citing works

Effects of Hydrocortisone on the Regulation of Blood Pressure: Results From a Randomized Controlled Trial

Buning, J. W., van Faassen, M. H. J. R., Brummelman, P., Dullaart, R. P. F., van den Berg, G., van der Klauw, M. M., Kerstens, M. N., Stegeman, C. A., Kobold, A. C. M., Kema, I. P., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2216 · Cited by 50 · see citing works

Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency

Nilsson, A. G., Marelli, C., Fitts, D., Bergthorsdottir, R., Burman, P., Dahlqvist, P. M., Ekman, B., Engström, B. E., Olsson, T., Ragnarsson, Ó., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0327 · Cited by 49 · see citing works

BC l I polymorphism of the glucocorticoid receptor gene is associated with increased obesity, impaired glucose metabolism and dyslipidaemia in patients with Addison's disease

Giordano, R., Marzotti, S., Berardelli, R., Karamouzis, I., Brozzetti, A., D’Angelo, V., Mengozzi, G., Mandrile, G., Giachino, D. F., Migliaretti, G., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04439.x · Cited by 47 · see citing works

Hair cortisol in the evaluation of Cushing syndrome

Hodes, A. D., Lodish, M. B., Tirosh, A., Meyer, J. S., Belyavskaya, E., Lyssikatos, C., Rosenberg, K. L., Demidowich, A. P., Swan, J., Jonas, N., et al. (2017) · Endocrine · doi:10.1007/s12020-017-1231-7 · Cited by 46 · see citing works

Pituitary Diseases and Bone

Mazziotti, G., Chiavistelli, S., & Giustina, A. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2014.10.014 · Cited by 46 · see citing works

The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients

Ragnarsson, O., Mattsson, A. F., Monson, J. P., Filipsson Nyström, H., Åkerblad, A.-C., Kołtowska-Häggström, M., & Johannsson, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0397 · Cited by 46 · see citing works

Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects

Giustina, A., Doga, M., Bodini, C., Girelli, A., Legati, F., Bossoni, S., & Romanelli, G. (1990) · European Journal of Endocrinology · doi:10.1530/acta.0.1220206 · Cited by 45 · see citing works

Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study

Pedersini, R., Monteverdi, S., Mazziotti, G., Amoroso, V., Roca, E., Maffezzoni, F., Vassalli, L., Rodella, F., Formenti, A. M., Frara, S., et al. (2017) · Bone · doi:10.1016/j.bone.2017.01.013 · Cited by 45 · see citing works

Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Ceccato, F., Barbot, M., Albiger, N., Zilio, M., De Toni, P., Luisetto, G., Zaninotto, M., Greggio, N. A., Boscaro, M., Scaroni, C., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0104 · Cited by 42 · see citing works

Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone

Pia, A. R., Vignani, F., Attard, G., Tucci, M., Bironzo, P., Scagliotti, G. V., Arlt, W., Terzolo, M., & Berruti, A. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.03.003 · Cited by 42 · see citing works

Impaired health‐related quality of life in Addison's disease – impact of replacement therapy, comorbidities and socio‐economic factors

Kluger, N., Matikainen, N., Sintonen, H., Ranki, A., Roine, R. P., & Schalin‐Jäntti, C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12484 · Cited by 41 · see citing works

Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia

Falhammar, H., Nyström, H. F., & Thorén, M. C. (2014) · Endocrine · doi:10.1007/s12020-013-0161-2 · Cited by 39 · see citing works

Altered insulin requirement in patients with type 1 diabetes and primary adrenal insufficiency receiving standard glucocorticoid replacement therapy

Elbelt, U., Hahner, S., & Allolio, B. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-1003 · Cited by 37 · see citing works

Hydrocortisone dose influences pain, depressive symptoms and perceived health in adrenal insufficiency: a randomized controlled trial

Werumeus Buning, J., Brummelman, P., Koerts, J., Dullaart, R. P. F., van den Berg, G., van der Klauw, M. M., Sluiter, W. J., Tucha, O., Wolffenbuttel, B. H. R., & van Beek, A. P. (2016) · Neuroendocrinology · doi:10.1159/000442985 · Cited by 37 · see citing works

Health-Related Quality of Life in Pituitary Diseases

Crespo, I., Valassi, E., Vives, A. S., & Webb, S. M. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2014.10.013 · Cited by 36 · see citing works

Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency

Benson, S., Neumann, P., Unger, N., Schedlowski, M., Mann, K., Elsenbruch, S., & Petersenn, S. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0351 · Cited by 34 · see citing works

Management of adjuvant mitotane therapy following resection of adrenal cancer

Terzolo, M., Ardito, A., Zaggia, B., Laino, F., Germano, A., Francia, S. D., Daffara, F., & Berruti, A. (2012) · Endocrine · doi:10.1007/s12020-012-9719-7 · Cited by 33 · see citing works

Growth Hormone (GH) Responses to GH-Releasing Hormone Alone or Combined with Arginine in Patients with Adrenal Incidentaloma: Evidence for Enhanced Somatostatinergic Tone

Terzolo, M., Bossoni, S., Alı̀, A., Doga, M., Reimondo, G., Milani, G., Peretti, P., Manelli, F., Angeli, A., & Giustina, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6531 · Cited by 31 · see citing works

Evaluation of two replacement regimens in primary adrenal insufficiency patients. Effect on clinical symptoms, health-related quality of life and biochemical parameters

Alonso, N., Granada, M. L., Lucas, A., Salinas, I., Reverter, J., Oriol, A., & Sanmartí, A. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03345290 · Cited by 30 · see citing works

Poor quality of life, depressed mood, and memory impairment may be mediated by sleep disruption in patients with Addison's disease

Henry, M., Wolf, P., Ross, I., & Thomas, K. (2015) · Physiology and Behavior · doi:10.1016/j.physbeh.2015.08.011 · Cited by 29 · see citing works

Cardiovascular Risk Factors in Patients with Addison's Disease: A Comparative Study of South African and Swedish Patients

Ross, I. L., Bergthorsdottir, R., Levitt, N., Dave, J. A., Schatz, D., Marais, D., & Johannsson, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090768 · Cited by 29 · see citing works

Urinary Free Cortisol in the Assessment of Hydrocortisone Replacement Therapy

Trainer, P. J., McHardy, K. C., Harvey, R., & REID, I. W. (1993) · Hormone and Metabolic Research · doi:10.1055/s-2007-1002056 · Cited by 28 · see citing works

Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin‐deficient hypopituitary male patients

Behan, L., Rogers, B., Hannon, M. J., O’Kelly, P., Tormey, W. P., Smith, D., Thompson, C. J., & Agha, A. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04074.x · Cited by 27 · see citing works

Clinical and molecular manifestation of fifteen 17OHD patients: a novel mutation and a founder effect

Han, B., Xue, L., Fan, M., Zhao, S., Liu, W., Zhu, H., Cheng, T., Lu, Y., Cheng, K., Song, H., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0957-y · Cited by 26 · see citing works

Comparison of Absorption of Cortisone Acetate and Hydrocortisone Hemisuccinate*

Fariss, B. L., Hane, S., Shinsako, J., & Forsham, P. H. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-47-5-1137 · Cited by 23 · see citing works

Dioxin-induced fetal growth retardation: the role of a preceding attenuation in the circulating level of glucocorticoid

Hattori, Y., Takeda, T., Fujii, M., Taura, J., Ishii, Y., & Yamada, H. (2014) · Endocrine · doi:10.1007/s12020-014-0257-3 · Cited by 21 · see citing works

Plasma lipoproteins and adrenocortical hormones in men — positive association of low density lipoprotein cholesterol with plasma cortisol concentration

Nanjee, M. N., & Miller, N. E. (1989) · Clinica Chimica Acta · doi:10.1016/0009-8981(89)90342-2 · Cited by 20 · see citing works

Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency

Rousseau, E., Joubert, M., Trzepla, G., Parienti, J. J., Freret, T., Vanthygem, M. C., Desailloud, R., Lefebvre, H., Coquerel, A., Reznik, Y., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135975 · Cited by 20 · see citing works

An observational study on adrenal insufficiency in a French tertiary centre: Real life versus theory

Castinetti, F., Sahnoun, M., Albarel, F., Morange, I., Philippon, M., Conte‐Devolx, B., & Brue, T. C. (2015) · Annales d Endocrinologie · doi:10.1016/j.ando.2014.11.004 · Cited by 19 · see citing works

Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors

Jadhavar, P. S., Ramachandran, S. A., Riquelme, E., Gupta, A., Quinn, K. P., Shivakumar, D., Ray, S. S., Zende, D., Nayak, A. K., Miglani, S. K., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.09.058 · Cited by 18 · see citing works

Impaired growth hormone secretion associated with low glucocorticoid levels: an experimental model for the Giustina effect

Giustina, A., & Mazziotti, G. (2014) · Endocrine · doi:10.1007/s12020-014-0278-y · Cited by 14 · see citing works

A model for measuring the health burden of classic congenital adrenal hyperplasia in adults

Hummel, S., Sadler, S., Whitaker, M. J., Ara, R., Dixon, S., & Ross, R. J. M. (2016) · Clinical Endocrinology · doi:10.1111/cen.13060 · Cited by 12 · see citing works

Artificial Respiration

Lucas, B. G. B., & Whitcher, H. W. (1958) · BMJ · doi:10.1136/bmj.2.5101.887 · Cited by 11 · see citing works

Optimization of glucocorticoid replacement therapy: the long‐term effect on bone mineral density

Peacey, S. R., Guo, C. Y., Eastell, R., & Weetman, A. P. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00787.x · Cited by 10 · see citing works

Dose Distribution in Hydrocortisone Replacement Therapy Has a Significant Influence on Urine Free Cortisol Excretion

Bliesener, N., Steckelbroeck, S., Redel, L., & Klingmüller, D. (2003) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2003-44292 · Cited by 10 · see citing works

Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients

Sideris, S., Aoun, F. Y., Martinez, C. N., Latifyan, S., Awada, A. H., Costante, G., & Gil, T. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0430-z · Cited by 8 · see citing works

Immediate versus modified release hydrocortisone in mitotane‐treated patients with adrenocortical cancer

Weigel, M., Hahner, S., Sherlock, M., Agha, A., Behan, L., Stewart, P. M., Arlt, W., Beier, D., Frey, K. R., Zopf, K., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13302 · Cited by 7 · see citing works

Adrenocorticotropin

Wang, O., & Majzoub, J. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10003-3 · Cited by 5 · see citing works

Improving glucocorticoid replacement in patients with adrenal insufficiency

Johannsson, G. (2016) · Endocrine · doi:10.1007/s12020-016-0929-2 · Cited by 4 · see citing works

A randomized trial of abiraterone acetate (AA) administered with 1 of 4 glucocorticoid (GC) regimens in metastatic castration-resistant prostate cancer (mCRPC) patients (pts).

Attard, G., Merseburger, A. S., Sternberg, C. N., Cerbone, L., Recine, F., Jones, R. J., Feyerabend, S., Berruti, A., Joniau, S., Schatteman, P., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.2_suppl.261 · Cited by 2 · see citing works

Amiloride effects on abiraterone antiproliferative activity in prostate cancer cells in vitro and on clinical management of abiraterone induced mineralocorticoid excess syndrome.

Valcamonico, F., Bedussi, F., Galli, D., Volta, A. D., Fragni, M., Vezzoli, S., Ferrari, V. D., Lazzari, B., Ferrari, L., Ferrari, F. D., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.2_suppl.175 · Cited by 2 · see citing works

INDICATIONS FOR PERFORMIING WILDE'S INCISION

Hamilton, E. S. B. (1930) · BMJ · doi:10.1136/bmj.2.3640.619-a · Cited by 1 · see citing works

A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update

Giustina, A., Barkan, A. L., Beckers, A. M., Biermasz, N. R., Biller, B. M. K., Boguszewski, C. L., Bolanowski, M., Bonert, V. S., Bronstein, M. D., Casanueva, F. F., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz096 · Cited by 371 · see citing works

Clinical Biology of the Pituitary Adenoma

Melmed, S. K., Kaiser, U. B., Lopes, M. B. S., Bertherat, J. Y., Syro, L. V., Raverot, G., Reincke, M., Johannsson, G., Beckers, A. M., Fleseriu, M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac010 · Cited by 342 · see citing works

Adrenal insufficiency

Hahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223 · see citing works

Endocrine and metabolic aspects of the COVID-19 pandemic

Marazuela, M., Giustina, A., & Puig‐Domingo, M. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09569-2 · Cited by 218 · see citing works

Pituitary Diseases and Bone

Mazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181 · see citing works

Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline

Newman, C. B., Blaha, M. J., Boord, J. B., Cariou, B., Chait, A., Fein, H. G., Ginsberg, H. N., Goldberg, I. J., Murad, M. H., Subramanian, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa674 · Cited by 180 · see citing works

New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays

Javorsky, B. R., Raff, H., Carroll, T. B., Algeciras-Schimnich, A., Singh, R. J., Colón-Franco, J. M., & Findling, J. W. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab022 · Cited by 166 · see citing works

Hypopituitarism

Fleseriu, M., Christ‐Crain, M., Langlois, F., Gadelha, M. R., & Melmed, S. K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00342-8 · Cited by 120 · see citing works

COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology

Puig‐Domingo, M., Marazuela, M., Yıldız, B. O., & Giustina, A. (2021) · Endocrine · doi:10.1007/s12020-021-02734-w · Cited by 109 · see citing works

Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment

Ferraù, F., Albani, A., Ciresi, A., Giordano, C. S. D. S., & Cannavò, S. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00358 · Cited by 105 · see citing works

COVID-19 and the pituitary

Frara, S., Allora, A., Castellino, L., di Filippo, L., Loli, P., & Giustina, A. (2021) · Pituitary · doi:10.1007/s11102-021-01148-1 · Cited by 97 · see citing works

Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency

Al Alawi, A. M., Nordenström, A., & Falhammar, H. (2019) · Endocrine · doi:10.1007/s12020-018-01835-3 · Cited by 77 · see citing works

Pituitary Tumors Centers of Excellence.

Frara, S., Rodríguez-Carnero, G., Formenti, A. M., Olmos, M. M., Giustina, A., & Casanueva, F. (2020) · Endocrinology and metabolism clinics of North America (Print) · doi:10.1016/j.ecl.2020.05.010 · Cited by 62 · see citing works

Effects of Medical Treatment of Prostate Cancer on Bone Health

Formenti, A. M., Volta, A. D., di Filippo, L., Berruti, A., & Giustina, A. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.12.004 · Cited by 45 · see citing works

Osteopathy in mild adrenal Cushing’s syndrome and Cushing disease

Frara, S., Allora, A., di Filippo, L., Formenti, A. M., Loli, P., Polizzi, E., Tradati, D., Ulivieri, F. M., & Giustina, A. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101515 · Cited by 43 · see citing works

Acromegaly and Bone: An Update

Giustina, A. (2023) · Endocrinology and Metabolism · doi:10.3803/enm.2023.601 · Cited by 42 · see citing works

Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study

Mazziotti, G., Battista, C., Maffezzoni, F., Chiloiro, S., Ferrante, E., Prencipe, N., Grasso, L. F. S., Gatto, F., Olivetti, R., Arosio, M., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa363 · Cited by 41 · see citing works

Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis

Hudson, J., Cruickshank, M., Quinton, R., Aucott, L. S., Wu, F. C. W., Grossmann, M., Bhasin, S., Snyder, P. J., Ellenberg, S. S., Travison, T. G., et al. (2023) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(23)00169-1 · Cited by 41 · see citing works

Bone safety of dual-release hydrocortisone in patients with hypopituitarism

Frara, S., Chiloiro, S., Porcelli, T., Giampietro, A., Mazziotti, G., Marinis, L. D., & Giustina, A. (2018) · Endocrine · doi:10.1007/s12020-017-1512-1 · Cited by 38 · see citing works

COVID-19 and hypopituitarism

Frara, S., Loli, P., Allora, A., Santini, C., di Filippo, L., Mortini, P., Fleseriu, M., & Giustina, A. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09672-y · Cited by 38 · see citing works

Effects of endocrine disorders on lipids and lipoproteins

Newman, C. B. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101667 · Cited by 37 · see citing works

Hypoglycaemia in adrenal insufficiency

Lee, S. C., Baranowski, E. S., Sakremath, R., Saraff, V., & Mohamed, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1198519 · Cited by 32 · see citing works

Novel approaches to bone comorbidity in Cushing’s disease: an update

Frara, S., di Filippo, L., Doga, M., Loli, P., Casanueva, F. F., & Giustina, A. (2022) · Pituitary · doi:10.1007/s11102-022-01252-w · Cited by 32 · see citing works

Improved salivary cortisol rhythm with dual-release hydrocortisone

Ceccato, F., Selmin, E., Sabbadin, C., Costa, M. D., Antonelli, G., Plebani, M., Barbot, M., Betterle, C., Boscaro, M., & Scaroni, C. M. (2018) · Endocrine Connections · doi:10.1530/ec-18-0257 · Cited by 29 · see citing works

Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: the CORTI-COVID study

Martino, M., Aboud, N., Cola, M. F., Giancola, G., Ciarloni, A., Salvio, G., & Arnaldi, G. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01422-2 · Cited by 26 · see citing works

Evaluating the Impact of Acromegaly on Quality of Life

Coopmans, E. C., Andela, C. D., Claessen, K. M. J. A., & Biermasz, N. R. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.04.004 · Cited by 26 · see citing works

Approach to the Patient With Hypothalamic Obesity

Shoemaker, A. H., & Tamaroff, J. G. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac678 · Cited by 25 · see citing works

Higher Risk of Fragility Fractures in Prostate Cancer Patients Treated with Combined Radium-223 and Abiraterone: Prednisone May Be the Culprit

Volta, A. D., Formenti, A. M., & Berruti, A. (2019) · European Urology · doi:10.1016/j.eururo.2019.01.026 · Cited by 25 · see citing works

Glycometabolic Alterations in Secondary Adrenal Insufficiency: Does Replacement Therapy Play a Role?

Graziadio, C., Hasenmajer, V., Venneri, M. A., Gianfrilli, D., Isidori, A. M., & Sbardella, E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00434 · Cited by 25 · see citing works

New insights into the vitamin D/PTH axis in endocrine-driven metabolic bone diseases

di Filippo, L., Bilezikian, J. P., CANALIS, E. M., Terenzi, U., & Giustina, A. (2024) · Endocrine · doi:10.1007/s12020-024-03784-6 · Cited by 22 · see citing works

Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of WHO fracture risk assessment tool (FRAX) and bone mineral density in real-life clinical practice

Mazziotti, G., Vena, W., Pedersini, R., Piccini, S., Morenghi, E., Cosentini, D., Zucali, P. A., Torrisi, R., Sporeni, S., Simoncini, E., et al. (2022) · Journal of bone oncology · doi:10.1016/j.jbo.2022.100421 · Cited by 22 · see citing works

Evolving pituitary hormone deficits in primarily isolated GHD: a review and experts’ consensus

Binder, G., Schnabel, D., Reinehr, T., Pfäffle, R. W., Dörr, H., Bettendorf, M., Hauffa, B. P., & Woelfle, J. (2020) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-020-00108-2 · Cited by 21 · see citing works

Long COVID and pituitary dysfunctions: a bidirectional relationship?

di Filippo, L., Franzese, V., Santoro, S., Doga, M., & Giustina, A. (2024) · Pituitary · doi:10.1007/s11102-024-01442-8 · Cited by 19 · see citing works

Characteristics of Korean Patients with Primary Adrenal Insufficiency: A Registry-Based Nationwide Survey in Korea

Hong, A. R., Ryu, O., Kim, S. Y., Kim, S. W., The Korean Adrenal Gland and Endocrine Hypertension Study Group, & Korean Endocrine Society (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.4.466 · Cited by 17 · see citing works

Central adrenal insufficiency: who, when, and how? From the evidence to the controversies – an exploratory review

Bitencourt, M. R., Batista, R. L., Biscotto, I. P., & Carvalho, L. R. S. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000493 · Cited by 14 · see citing works

Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes

Akirov, A., Rudman, Y., & Fleseriu, M. (2024) · Pituitary · doi:10.1007/s11102-024-01391-2 · Cited by 12 · see citing works

Metabolic comorbidities of adrenal insufficiency: Focus on steroid replacement therapy and chronopharmacology

Guarnotta, V., Amodei, R., & Giordano, C. S. D. S. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.07.003 · Cited by 12 · see citing works

Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries

Demarchis, L., Chiloiro, S., Giampietro, A., Marinis, L. D., Bianchi, A., Fleseriu, M., & Pontecorvi, A. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09957-6 · Cited by 11 · see citing works

Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency

Gasco, V., Giannelli, J., Campioni, L., Arvat, E., Ghigo, E., Grottoli, S., Maccario, M., & Giordano, R. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01940-1 · Cited by 11 · see citing works

Approach to patients with bilateral adrenal incidentalomas

Vassiliadi, D. A., Partsalaki, E., & Tsagarakis, S. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000536 · Cited by 10 · see citing works

Morphometric vertebral fractures in patients with castration-resistant prostate cancer undergoing treatment with radium-223: a longitudinal study in the real-life clinical practice

Mazziotti, G., Rodari, M., Gelardi, F., Tosi, G., Zucali, P. A., Pepe, G., & Chiti, A. (2020) · Endocrine · doi:10.1007/s12020-020-02277-6 · Cited by 10 · see citing works

Vitamin D in pituitary driven osteopathies

Chiloiro, S., Costanza, F., Riccardi, E., Giampietro, A., Marinis, L. D., Bianchi, A., Pontecorvi, A., & Giustina, A. (2024) · Pituitary · doi:10.1007/s11102-024-01439-3 · Cited by 10 · see citing works

Decreased quality of life (QoL) in hypopituitary patients: involvement of glucocorticoid replacement and radiation therapy

Ajmal, A., McKean, E. L., Sullivan, S. E., & Barkan, A. L. (2018) · Pituitary · doi:10.1007/s11102-018-0918-y · Cited by 10 · see citing works

Skeletal fragility induced by overtreatment of adrenal insufficiency

Falhammar, H. (2017) · Endocrine · doi:10.1007/s12020-017-1501-4 · Cited by 10 · see citing works

Modern approach to bone comorbidity in prolactinoma

Uygur, M. M., Menotti, S., Santoro, S., & Giustina, A. (2024) · Pituitary · doi:10.1007/s11102-024-01469-x · Cited by 10 · see citing works

Extended-release Hydrocortisone Formulations—Is There a Clinically Meaningful Benefit?

Steintorsdottir, S. D., Øksnes, M., Jørgensen, A. P., & Husebye, E. S. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae822 · Cited by 9 · see citing works

Glucocorticoid replacement in Addison disease

Choudhury, S., & Meeran, K. M. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0049-6 · Cited by 9 · see citing works

Novel agents to treat adrenal insufficiency: findings of preclinical and early clinical trials

Peel, A., Rushworth, R. L., & Torpy, D. J. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2311207 · Cited by 8 · see citing works

Morphometric vertebral fractures at hospitalization associate with Long COVID occurrence

di Filippo, L., Doga, M., Mangini, F., Gifuni, L., Sahagun, S. J., Rovere, P. Q., Rosen, C. J., & Giustina, A. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02544-1 · Cited by 8 · see citing works

Redefining ITT cortisol thresholds on Abbott platforms to prevent misdiagnosis of adrenal insufficiency

Lazarus, K., Hayes, A., Narula, K., Papadopolou, D., Tan, T., Meeran, K. M., & Choudhury, S. (2024) · Clinical Endocrinology · doi:10.1111/cen.15074 · Cited by 8 · see citing works

Systematic review and meta-analysis of the metabolic effects of modified-release hydrocortisone versus standard glucocorticoid replacement therapy in adults with adrenal insufficiency

Bannon, C. A., Gallacher, D., Hanson, P., Randeva, H. S., Weickert, M. O., & Barber, T. M. (2020) · Clinical Endocrinology · doi:10.1111/cen.14275 · Cited by 8 · see citing works

What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study

Puglisi, S., Rossini, A., Tabaro, I., Cannavò, S., Ferraù, F., Ragonese, M., Borretta, G., Pellegrino, M., Dughera, F., Parisi, A., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01386-3 · Cited by 8 · see citing works

Early Metabolic Benefits of Switching Hydrocortisone to Modified Release Hydrocortisone in Adult Adrenal Insufficiency

Bannon, C. A. M., Border, D., Hanson, P., Hattersley, J. G., Weickert, M. O., Grossman, A. B., Randeva, H. S., & Barber, T. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.641247 · Cited by 8 · see citing works

High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma

Frara, S., Uygur, M. M., Bolamperti, F. M., di Filippo, L., Doga, M., Ferrari, F., Losa, M., Mortini, P., & Giustina, A. (2024) · Pituitary · doi:10.1007/s11102-024-01394-z · Cited by 7 · see citing works

Skeletal fragility in pituitary disease: how can we predict fracture risk?

Bioletto, F., Berton, A. M., Barale, M., Aversa, L. S., Sauro, L., Presti, M., Mocellini, F., Sagone, N., Ghigo, E., Massimo, P., et al. (2024) · Pituitary · doi:10.1007/s11102-024-01447-3 · Cited by 7 · see citing works

Vitamin D and hip protectors in osteosarcopenia: a combined hip fracture preventing approach

Giustina, A., & Giustina, A. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09907-8 · Cited by 7 · see citing works

Tiered healthcare in South Africa exposes deficiencies in management and more patients with infectious etiology of primary adrenal insufficiency

Mofokeng, T. R. P., Ndlovu, K. C. Z., Beshyah, S., & Ross, I. L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241845 · Cited by 7 · see citing works

Partial versus total adrenalectomy for pheochromocytoma: a population-based comparison of outcomes

Bhambhvani, H. P., Daneshvar, M., Peterson, D. J., & Ball, M. W. (2021) · International Urology and Nephrology · doi:10.1007/s11255-021-03004-4 · Cited by 7 · see citing works

Acromegaly complications: an update

Giustina, A., & Fleseriu, M. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag114 · Cited by 6 · see citing works

High prevalence of overweight/obesity and dyslipidemia in patients with intracranial germ cell tumors

Wang, S., Zhang, Y., Zhou, X., Zhang, K., Zhang, Y., Yao, Y., Chen, S., Pan, H., & Zhu, H. (2022) · Pituitary · doi:10.1007/s11102-022-01274-4 · Cited by 6 · see citing works

Bone safety of dual-release hydrocortisone in patients with autoimmune primary adrenal insufficiency

Bioletto, F., Barale, M., Parasiliti‐Caprino, M., Giannelli, J., Campioni, L., Cappiello, V., Carlo, M. C. D., Ghigo, E., Massimo, P., & Giordano, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1234237 · Cited by 7 · see citing works

Monitoring adrenal insufficiency through salivary steroids: a pilot study

Tucci, L., Fanelli, F., Improta, I., Bissi, V., Lena, C., Galante, G., Mezzullo, M., Magagnoli, M., Lalumera, A. B., Colombin, G., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae037 · Cited by 6 · see citing works

Progression of Vertebral Fractures in Patients with Adrenocortical Carcinoma Undergoing Mitotane Therapy

Cosentini, D., Grisanti, S., Hadoux, J., Libé, R., Frigerio, M., Laganà, M., Deschamps, F., Zamparini, M., Lamartina, L., Pedersini, R., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab899 · Cited by 6 · see citing works

Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy

Chiloiro, S., Vicari, A., Mongelli, G., Costanza, F., Giampietro, A., Mattogno, P. P., Lauretti, L., Olivi, A., Marinis, L. D., Doglietto, F., et al. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09898-6 · Cited by 5 · see citing works

Medical Treatment of Cushing’s Syndrome

Guignat, L., & Bertherat, J. Y. (2025) · Endocrinology and Metabolism · doi:10.3803/enm.2024.501 · Cited by 5 · see citing works

Treating Hypopituitarism in the Over 65s: Review of Clinical Studies

Paragliola, R. M., Locantore, P., Corsello, S. M., & Salvatori, R. (2023) · Clinical Interventions in Aging · doi:10.2147/cia.s370782 · Cited by 5 · see citing works

Effects on bone health of glucocorticoid replacement therapy in primary and secondary adrenal insufficiency: A review

Bentivegna, G., Osella, G., Pia, A., & Terzolo, M. (2018) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2018.02.008 · Cited by 5 · see citing works

Addison’s disease in pregnancy: Case report, management, and review of the literature

Margulies, S. L., Corrigan, K., Bathgate, S. L., & Macri, C. J. (2019) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-190231 · Cited by 5 · see citing works

Increased risk of osteoporotic fractures and osteoporosis in patients with Addison's disease in Sweden: A nationwide population‐based cohort study

Stergianos, S., Spelman, T. D., Eriksson, D., Öster, S., Björnsdóttir, S., Kämpe, O., Skov, J., & Bensing, S. (2025) · Journal of Internal Medicine · doi:10.1111/joim.20085 · Cited by 4 · see citing works

Prediction of diabetes mellitus induced by steroid overtreatment in adrenal insufficiency

Guarnotta, V., Tomasello, L., & Giordano, C. S. D. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-04904-w · Cited by 4 · see citing works

Pathophysiology and evaluation of bone health in adrenal diseases

Uygur, M. M., di Filippo, L., Frara, S., Menotti, S., & Giustina, A. (2025) · Endocrine · doi:10.1007/s12020-025-04260-5 · Cited by 4 · see citing works

Pulsatile Subcutaneous Hydrocortisone Replacement in Primary Adrenal Insufficiency

Šimůnková, K., Løvås, K., Methlie, P., Jovanovic, N., Bifulco, E., Brønstad, I., Lightman, S. L., Husebye, E. S., & Øksnes, M. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2092-5228 · Cited by 4 · see citing works

Multiple benefits from dual release hydrocortisone: a “hard” view from bones

Vassiliadi, D. A., & Tsagarakis, S. (2018) · Endocrine · doi:10.1007/s12020-018-1628-y · Cited by 4 · see citing works

Diagnosis of adrenal insufficiency in children: a survey among pediatric endocrinologists in North America

Silva, C., Patel, T., & Lam, C. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0444 · Cited by 3 · see citing works

Adrenal functional reserve in the full spectrum of chronic kidney disease

Rodríguez‐Gutiérrez, R., González-González, J. G., Martínez‐Rodríguez, A., Burciaga-Jimenez, E., Solís, R. C., González-Colmenero, A. D., Ramírez-García, L. A., Mariño-Velasco, S., & Barrera-Flores, F. J. (2022) · Gaceta Médica de México · doi:10.24875/gmm.m21000605 · Cited by 3 · see citing works

Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study

Piasentier, A., Birtolo, M. F., Turci, B., Vena, W., Fanti, A., Morenghi, E., Gentile, L. M. S., Balzarini, L., Bossi, A. C., Berruti, A., et al. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.09.201 · Cited by 2 · see citing works

Professional practices in the management of adrenal insufficiency in two tertiary referral hospitals (Tunis, Tunisia).

Chihaoui, M., Boukhadeja, H., Khessairi, N., Oueslati, I., Amor, Z. B., Chaker, F., & Yazidi, M. (2022) · PubMed Central · Cited by 2 · see citing works

Gaps in the management of adrenal insufficiency in melanoma survivors: a retrospective cohort study

Lin, W., Wang, W. J., Hodi, F. S., & Min, L. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102984 · Cited by 2 · see citing works

Improved salivary cortisol rhythm with dual-release hydrocortisone

Ceccato, F., Selmin, E., Sabbadin, C., Costa, M. D., Antonelli, G., Plebani, M., Barbot, M., Betterle, C., Boscaro, M., & Scaroni, C. M. (2018) · Endocrine Abstracts · doi:10.1530/endoabs.56.p56 · Cited by 2 · see citing works

Effect of glucocorticoids on bone metabolism in replacement therapy of adrenal insufficiency. Literature review

Yukina, M., Chernova, M. O., Nuralieva, N., Eremkina, A., Troshina, E., Melnichenko, G. A., & Mokrysheva, N. (2020) · Obesity and Metabolism · doi:10.14341/omet12700 · Cited by 1 · see citing works

Leukocytosis may be an indicator of replacement with supraphysiological dose in adrenal insufficiency: relationship with comorbidities and impaired muscle strength

Mutlu, Ü., Rasulova, N., Hacışahinoğulları, H., Yalın, G. Y., Gül, N., Üzüm, A. K., & Selçukbiricik, Ö. S. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02668-4 · Cited by 1 · see citing works

Hydrocortisone replacement therapy in patients with glucocorticoid withdrawal syndrome after cessation of glucocorticoid treatment: REPLACE, a multicentre, randomised, double-blinded, placebo-controlled, 16-week study protocol

Dreyer, A. F., Hansen, S. B., Borresen, S. W., Al-Jorani, H., Bislev, L. S., Boesen, V. B., Christensen, L. L., Glintborg, D., Jensen, R. C., Jørgensen, N. T., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-111334 · Cited by 1 · see citing works

Reserva funcional adrenal en el espectro completo de la enfermedad renal crónica

Rodríguez‐Gutiérrez, R., González-González, J. G., Martínez‐Rodríguez, A., Burciaga-Jimenez, E., Solís, R. C., González-Colmenero, A. D., Ramírez-García, L. A., Mariño-Velasco, S., & Barrera-Flores, F. J. (2021) · Gaceta Médica de México · doi:10.24875/gmm.21000441 · Cited by 1 · see citing works

Reversible suppression of hypothalamo–pituitary–adrenal axis in Addison’s disease due to ethinyl oestradiol-induced increase in total cortisol

Lewandowski, K. C., Głuchowska, M., Karbownik‐Lewińska, M., & Lewiñski, A. (2024) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-24-0055 · Cited by 1 · see citing works

Nationellt miljökvalitetsmål på lokal nivå

Engkvist, F. (2011)

Managing patients with endocrine dysfunction during COVID-19: Review of literatures

Patro, P. M., & Rao, K. V. J. (2020) · Journal of Medical and Scientific Research · doi:10.17727/jmsr.2020/8s1-11

Clinical Characteristics, Etiology, and Outcome of Patients with Adrenal Crisis: A Single-Center Experience

Nabi, T., Rafiq, N., Rahman, M. H. U., & Bhat, N. (2021) · Journal of Medical Sciences · doi:10.4103/jmedsci.jmedsci_298_20

Research Activities Calendar - Research Division

shecanip (2011)

La gestione della salute dell’osso nel paziente in deprivazione androgenica per carcinoma della prostata

Piccini, S., Ariano, S. A., Zucali, P. A., Vincenzo, F. D., Franzese, C., Scorsetti, M., Lania, A. G., & Mazziotti, G. (2022) · L Endocrinologo · doi:10.1007/s40619-022-01105-5

Minimizing Cardiometabolic Risk Factors in Patients with Acromegaly

Yogi-Morren, D., & Kennedy, L. (2022) · Springer eBooks · doi:10.1007/978-3-030-99918-6_21

The effect of COVID-19 on patients with preexisting autoimmune diseases

Lastra, O. L. V., Navarro, A. O., Medina, G., Cruz-Domínguez, M. P., & Jara, L. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18566-3.00001-3

Adrenal Insufficiency in ASEAN: Barriers and Variations in Diagnosis and ManagementPreprint

Ramadoss, V., Cheong, L., Tan, L. K., Lazarus, K., Limumpornpetch, P., Puar, T. H. K., & Eng, P. C. (2025) · Research Square · doi:10.21203/rs.3.rs-7575544/v1

Newer Generation Immunoassays in Screening for Adrenal Insufficiency: Comparison of Baseline Morning Cortisol Levels With Cosyntropin Stimulation Testing

Shrestha, E., Albert, S. G., Ghimire, A., Canales, S. P., Iqbal, I., & Akande, R. O. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2026.03.001

Novel biomarkers to guide glucocorticoid replacement in primary adrenal insufficiency: a proof-of-concept study using copeptin-derived ratios

Bima, C., Campioni, L., Berton, A. M., Sola, C., Bergoglio, B., Carlo, M. C. D., Ponzetto, F., Settanni, F., Ceccato, F., Parasiliti‐Caprino, M., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02874-8

The metabolic effects of glucocorticoid replacement therapy in patients with secondary adrenal insufficiency due to hypothalamic-pituitary diseases: results from a retrospective and longitudinal study

Chiloiro, S., Vicari, A., Giampietro, A., Costanza, F., Calandrelli, R., Mattogno, P. P., D’Alessandris, Q. G., Gaudino, S., Marinis, L. D., Doglietto, F., et al. (2026) · Pituitary · doi:10.1007/s11102-026-01726-1

Continuous glucose monitoring reveals glycemic profile in adrenal insufficiency patients on glucocorticoid replacement

NING, C., Zhang, R., Liu, W., Zhou, X., Sun, Y., Han, X., Ji, L., & Ren, Q. (2026) · Endocrine Connections · doi:10.1530/ec-26-0304

Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy

Johannsson, G., Falorni, A., Skrtic, S., Lennernäs, H., Quinkler, M., Monson, J. P., & Stewart, P. M. (2015) · Clinical Endocrinology · doi:10.1111/cen.12603 · Cited by 122 · see citing works

Management of steroid replacement in adrenal insufficiency.

Koetz, K., Kienitz, T., & Quinkler, M. O. (2010) · PubMed · Cited by 11 · see citing works

What is the best long‐term management strategy for patients with primary adrenal insufficiency?

Quinkler, M., & Hahner, S. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04103.x · Cited by 50 · see citing works

Optimal glucocorticoid replacement in adrenal insufficiency

Øksnes, M., Ross, R. J. M., & Løvås, K. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.09.009 · Cited by 31 · see citing works

THERAPY OF ENDOCRINE DISEASE: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe

Grossman, A., Johannsson, G., Quinkler, M., & Zelissen, P. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0450 · Cited by 119 · see citing works